Comparative data: Cagrilintide: Achieved a 5.0% weight reduction in a 26-week Phase 2 clinical trial
A total of 40 participants were selected and randomized into two sequences in a double-blind, placebo-controlled crossover design, with a one-week washout period between treatments to eliminate carryover effects
Detached cells were suspended in the modified DMEM medium and seeded at 10 4 cells/well in 96-well microtiter plates (Costar, Corning) and incubated in the presence of 5% CO 2 at 37 C for 24 h
10.1111/j.1365-2362.2006.01618.x Hoensch H, Morgenstern I, Petereit G, Siepmann M, Peters WHM, Roelofs HMJ, Kirch W: Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system
Can tanned skin be white again